← Back to Search

Mindfulness Meditation for Chronic Lower Back Pain (STAMP Trial)

N/A
Waitlist Available
Led By Aleksandra E Zgierska, MD PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Inclusion Criteria (per self-report): English-speaking; age ≥ 21 years old; chronic low back pain (defined as a pain in lumbosacral region or sciatica for ≥3 months), with an average daily back pain score ≥3 on a 0-10 numerical rating scale (question from the Brief Pain Inventory), treated with ≥30 mg/day of morphine-equivalent dose for ≥3 months; at least moderate CLBP-related disability (≥21 score on the Oswestry Disability Index); capable of giving informed consent; willing to complete the study activities.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 months
Awards & highlights

STAMP Trial Summary

This trial will compare the effectiveness of mindfulness meditation to standard-of-care cognitive behavioral therapy in opioid-treated chronic low back pain.

Eligible Conditions
  • Chronic Lower Back Pain

STAMP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

STAMP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain Intensity
Physical Function
Secondary outcome measures
Daily Opioid Dose
Quality of Life
Other outcome measures
Anxiety Symptom Severity
Depression Symptom Severity
Opioid Medication Compliance
+1 more

Side effects data

From 2016 Phase 2 trial • 413 Patients • NCT01654289
9%
Musculoskeletal
6%
Cardiac Disorders
5%
General
100%
80%
60%
40%
20%
0%
Study treatment Arm
Exercise
Wait-list Control
Mindfulness Meditation

STAMP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness MeditationExperimental Treatment1 Intervention
Mindfulness Meditation intervention, adjunctive to usual care for opioid-treated chronic low back pain.
Group II: Cognitive Behavioral TherapyActive Control1 Intervention
Cognitive Behavioral Therapy intervention, adjunctive to usual care for opioid-treated chronic low back pain.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness Meditation
2017
Completed Phase 2
~4780

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,180 Previous Clinical Trials
3,591,580 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
548 Previous Clinical Trials
29,995,618 Total Patients Enrolled
Aleksandra E Zgierska, MD PhDPrincipal InvestigatorPenn State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there considerable facilities conducting this research in North America?

"Presently, 4 sites are participating in the study. These include Hershey, Salt Lake City and Madison as well as additional centres. To reduce any necessary travel demands on your part, it is advised to select a location that is nearby you geographically."

Answered by AI

Is this trial currently accepting enrollees?

"Clinicaltrials.gov confirms that the recruitment period for this clinical trial ended on November 30th 2022; however, there are 333 other studies currently open to new participants."

Answered by AI
~99 spots leftby Apr 2025